Pharmafile Logo

Zomi Communications Limited

Welcome to Zomi Communications! We deliver excellence in organisational and behavioural change, through an inspirational mix of training, coaching and consultancy. What makes Zomi Communications stand out from the crowd is that we inspire change from the inside out. Whether it’s training in leadership, management or communication, coaching for individuals or groups, team development or consultancy, we move people to where they want to be, by clarifying goals, identifying tools and applying learning to real life.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

51 St James's Avenue, Beckenham, Kent, BR3 4HF, United Kingdom
+44 (0)20 8650 6087

 Latest Content from PMHub 

Out of the shadows: Mental health in the Asia Pacific region

White Papers and Resources | February 9, 2018 | Inizio

In the first of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Asia

Research Partnership has published a new patient Living with Atopic Dermatitis (US) report

White Papers and Resources | February 9, 2018 | Inizio

Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. The report consists of 45-minute quantitative and 30-minute qualitative...

Research Partnership has published a new patient Living with Psoriasis (EU) report

White Papers and Resources | February 9, 2018 | Inizio

Living with Psoriasis is a report based on a new study conducted in the main 5EU markets and Belgium and the Netherlands (reports can be purchased for either 5EU or 7EU)....

New opportunities in emerging markets

White Papers and Resources | February 9, 2018 | Inizio

Published in Pharma Exec January 2018 by Rachel Howard

Lynch syndrome: a patient perspective

Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options,...

Battle of the Voice Assistants and Voice Search

At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung.

A Magical Makeover for Lucid Group

Lucid launch their new company branding

World Cancer Day and the role of people-centred care

How people-centred is current cancer care? To support #WorldCancerDay, we explore this question, and look at the ways we can individually and collectively reduce the burden of cancer.

Porterhouse speakers to focus on skills, data sharing and transparency at 17th TIPPA Meeting

Strategies to Improve Operations and Compliance in Medical Communications

Large-scale NHS commissioning models require new partnership approach from pharma

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative, joined up working